Organon has introduced the XE module of IDBS’s ActivityBase into its molecular pharmacology departments.
Organon is a long-time user of the ActivityBase test management system, having first installed it in 2002. It has extensively evaluated XE, the screening-specific module, since its release in September 2005.
Dr Steven van Helden, section head for screening and technology at Organon, said: 'The attraction of the XE module was the ability to perform verification, analysis and visualisation within one environment.’
